Paper294128
Effect of prolonged in vivo administration of leukocyte interferon on the mitogen responsiveness of human lymphocytes.
Einhorn S and 3 others. Acta Med Scand, 1979. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Effect of prolonged in vivo administration of leukocyte interferon on the mitogen responsiveness of human lymphocytes. Papers, record 294128. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/294128
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of prolonged in vivo administration of leukocyte interferon on the mitogen responsiveness of human lymphocytes.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| Lymphocyte Activation | Major topic |
| Mitogens | Major topic |
| Adult | |
| Aged | |
| Cells, Cultured | |
| Concanavalin A | |
| Female | |
| Humans | |
| Leukocyte Count | |
| Leukocytes | |
| Male | |
| Middle Aged | |
| Osteosarcoma | |
| Phytohemagglutinins | |
| Pokeweed Mitogens | |
| Time Factors |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6925979 | Decrease in the phagocytic activity of peripheral monocytes in patients treated with human interferon-alpha. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6925979 | PubMed |
| 6839546 | In vitro and in vivo effects of interferon on the response of human lymphocytes to mitogens. | Clin Exp Immunol | 1983 | https://conductscience.org/library/papers/6839546 | PubMed |
| 6559104 | Influence of human interferon-alpha therapy on cytotoxic functions of blood lymphocytes. Studies on lectin-dependent cellular cytotoxicity, antibody-dependent cellular cytotoxicity, and natural killer cell activity. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6559104 | PubMed |
| 6365781 | Functions of human neutrophilic granulocytes after in vivo exposure to interferon alpha. | Infect Immun | 1984 | https://conductscience.org/library/papers/6365781 | PubMed |
| 6173188 | Interferons and interferon inducers: development of clinical usefulness and therapeutic promise. | Drugs | 1982 | https://conductscience.org/library/papers/6173188 | PubMed |
| 3102351 | Enhancement of the B-cell response to Staphylococcus aureus Cowan strain 1 by natural human gamma interferon. | Immunology | 1987 | https://conductscience.org/library/papers/3102351 | PubMed |
| 2954635 | Influence of alpha-interferon therapy on blood lymphoid cells. Studies on antibody production, mixed lymphocyte culture response, mitogen responsiveness and 2'-5'oligoadenylate synthetase activity. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/2954635 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/294128
GET https://conductscience.org/api/papers/v1/294128/authors